Canadian Cannabis Plays to Watch Closely This March
Investors are keeping a close eye on top Canadian cannabis stocks this week. These companies often benefit from strong U.S. market ties. Although cannabis remains federally illegal in the U.S., state-level markets continue to expand rapidly. As of early 2025, over 40 U.S. states have legalized cannabis. According to New Frontier Data, the U.S. cannabis industry could reach $72 billion by 2030. This growth potential keeps Canadian firms with U.S. exposure in focus. Recently, the U.S. Department of Health and Human Services recommended rescheduling cannabis to Schedule III. This sparked renewed optimism around federal reform.
At the same time, smart traders use technical analysis to guide entries and exits. Key indicators like moving averages and RSI offer helpful insights. However, managing risk remains essential. Therefore, many investors set stop-loss orders to avoid overexposure. Although volatility is high, opportunity exists. As a result, stocks like TLRY, CGC, and VFF remain top candidates to monitor this week.
As Canada’s cannabis sector faces pressure, select stocks still offer long-term potential. In March 2025, three Canadian companies stand out due to their U.S. exposure, dispensary reach, and evolving financial positions. While regulatory challenges persist, many investors see the U.S. market as the growth engine. Canadian firms with U.S. footprints are now in focus. Let’s look closer at Tilray Brands, Canopy Growth Corporation, and Village Farms International.
[Read More] 3 Marijuana Stocks That Could Add Value To Your List
Top Canadian Cannabis Stocks to Watch in March 2025
- Tilray Brands, Inc. (NASDAQ: TLRY)
- Canopy Growth Corporation (NASDAQ: CGC)
- Village Farms International, Inc. (NASDAQ: VFF)
Tilray Brands, Inc. (TLRY)
Tilray Brands remains one of the most recognizable names in global cannabis. It operates across Canada and has made significant moves in the U.S. market. Although U.S. federal legalization has yet to occur, Tilray has positioned itself well for future expansion. Its largest presence in the U.S. is through strategic partnerships and acquisitions. These include craft breweries and wellness brands.
Tilray currently owns no cannabis dispensaries in the U.S. due to federal restrictions. However, it owns several alcohol and wellness brands. This strategy provides U.S. revenue streams while waiting for cannabis reform. Additionally, Tilray is a dominant player in Canada’s recreational market. It continues to lead in market share. Tilray also exports cannabis to international medical markets, further diversifying its reach.
Most importantly, Tilray’s long-term strategy focuses on becoming a powerhouse in cannabis, wellness, and beverages. The company remains focused on profitability. It also seeks to gain first-mover advantage once U.S. legalization advances.
In its latest quarterly earnings, Tilray reported revenue of $177 million. This was up 34% year-over-year. Much of the increase came from beverage and wellness sales. Cannabis revenue also grew modestly. Tilray reported a net loss of $46 million, though it was narrower than in previous quarters.
Operating expenses declined, showing progress toward profitability. Tilray also emphasized cost-cutting measures across its global operations. In addition, the company recently announced a $20 million share repurchase program. This signals confidence in its future performance. Despite volatility, Tilray remains a top Canadian cannabis stock this month.
[Read More] March 2025 Watchlist: Top Ancillary Cannabis Stocks Poised for Growth
Canopy Growth Corporation (CGC)
Canopy Growth Corporation was once the most significant cannabis stock in Canada by market cap. Though the company has faced financial hurdles, it remains a key player in the industry. Canopy’s strategy has shifted in recent years. The firm is now laser-focused on becoming profitable and capturing U.S. market share.
Its largest U.S. presence is through investments in Acreage Holdings and Wana Brands. Acreage operates dispensaries in several U.S. states, including New York, New Jersey, and Illinois. Canopy has the right to acquire Acreage fully once U.S. federal legalization occurs. Currently, it does not directly own dispensaries due to regulatory limitations.
Nonetheless, its U.S. footprint positions Canopy well for future growth. The company also sells CBD products through its Martha Stewart and BioSteel brands. These products are available in the U.S. and expand its American customer base. Overall, Canopy continues restructuring to prepare for broader North American expansion.
Canopy’s most recent quarterly results showed revenue of $62 million. This represented a 21% year-over-year decline. The cannabis segment remained weak, particularly in the Canadian market. However, the company reported stronger performance in its U.S. CBD and wellness divisions. Net losses for the quarter came in at $216 million. Though large, this marked a slight improvement from previous periods.
Management remains committed to reducing costs. It implemented job cuts and facility closures across Canada. These actions are expected to save $100 million annually. The company is also reducing debt through asset sales and restructuring efforts. Additionally, Canopy is working to simplify its business model. It aims to focus only on high-growth, profitable segments.
Though risky, Canopy offers potential upside if U.S. reforms materialize. It remains a speculative but promising Canadian cannabis stock to monitor this March.
[Read More] March 2025’s Top Cannabis Stocks: Key Players in the Growing Market
Village Farms International, Inc. (VFF)
Village Farms International operates in both the cannabis and produce industries. This dual strategy helps manage volatility in the cannabis space. The company owns Pure Sunfarms, a leading Canadian cannabis producer. It’s known for its cost-efficiency and high-quality flower.
Village Farms’ U.S. cannabis presence is currently limited. However, it has made efforts to enter the market through hemp-derived products and CBD. While it doesn’t own U.S. dispensaries, it maintains a U.S. footprint via its produce business. This gives it valuable distribution channels and infrastructure.
Importantly, Village Farms owns Texas-based greenhouse operations. These could be converted to cannabis cultivation if regulations allow. This positions the company well for future U.S. expansion. Although not as aggressive as Tilray or Canopy in U.S. cannabis, Village Farms maintains steady growth. Its focus on operational excellence gives it a competitive edge in the Canadian market.
In its latest quarterly earnings, Village Farms reported revenue of $71 million. Cannabis sales made up $29 million of that total. While down slightly from the prior year, gross margins improved. The company posted a net loss of $9.5 million. This was narrower than its previous quarterly loss. Importantly, Pure Sunfarms remained EBITDA positive.
The company highlighted strong demand for its dried flower products. It continues to gain market share in key Canadian provinces. Village Farms also increased its focus on international exports. Medical cannabis shipments to Australia and Germany are growing steadily.
In addition, management stressed its commitment to cost discipline. Village Farms reduced expenses and maintained a strong balance sheet. It ended the quarter with over $20 million in cash and minimal debt. With a diversified business model and improving margins, VFF stands out as a solid cannabis stock to track this month.
High Potential Canadian Marijuana Stocks for March 2025
Canadian cannabis companies continue to navigate a tough market environment. However, those with exposure to the U.S. and improving financials offer potential upside. Tilray, Canopy Growth, and Village Farms represent different strategies, but each holds long-term promise. As March 2025 unfolds, these three stocks remain ones to watch closely
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
